Earlier the US Food and Drug Administration (FDA) issued an emergency use authorization for the third COVID-19 vaccine, developed by Belgium-headquartered pharmaceutical firm Janssen. The drug was proved to be efficient to roughly 77 %.
An advisory panel with the US Centers for Disease Control and Prevention (CDC) voted on Sunday to approve the use of the Johnson & Johnson vaccine in opposition to the coronavirus for adults over 18.
Earlier on Saturday the US Food and Drug Administration (FDA) permitted the coronavirus vaccine developed by Johnson & Johnson for emergency within the nation.
According to the regulator, the vaccine is efficient in 66–67% of instances in stopping a illness of “moderate” severity and in 77–85% of instances in stopping “severe” instances.
This is the third vaccine permitted to be used within the US. In December 2020, the regulator permitted a vaccine developed in partnership between American firm Pfizer and German firm BioNTech, together with one other vaccine produced by Moderna.
DETAILS TO FOLLOW